Search results for: “Moderna”
-
CEPI Funds Multi-Variant Covid-19 Vaccine
Coalition for Epidemic Preparedness Innovations or CEPI is funding a new vaccine to protect against emerging Covid-19 variants and other coronaviruses.
-
Messenger RNA Developer ETF Launches
A new exchange traded fund or ETF is underway for individuals to invest in companies developing vaccines or therapies with messenger RNA.
-
Samsung, Biotech Partner on mRNA Vaccine Production
A developer of synthetic RNA products is partnering with Samsung Biologics to manufacture Covid-19 vaccines made with messenger RNA.
-
Joint Venture to Develop Stable RNA Covid-19 Vaccine
A developer of synthetic bio-based products from engineered yeast cells is joining with an immunotherapy drug maker to produce a stable RNA Covid-19 vaccine.
-
Book Review – The Premonition: A Pandemic Story
As the world struggles to overcome the Covid-19 pandemic, author Michael Lewis tells how the U.S. first struggled to identify and contain the virus.
-
Covid-19 Nasal Spray Vaccine Trial Underway
A clinical trial testing the safety of a Covid-19 vaccine from an engineered virus found in dogs and given as a nasal spray enrolled its first participant.
-
CEPI Funding Covid-19 Variant Vaccine
A biotechnology company is advancing a vaccine to protect against disease from SARS-CoV-2 variants, with new support from the organization CEPI.
-
Biotech Opens Gene Therapy Manufacturing Facility
A biotechnology company serving gene therapy developers is opening a manufacturing facility for engineered viruses that deliver gene therapies.
-
$60M Challenge Seeks RNA Bio-Production Network
A new challenge competition aims to build a distributed network of facilities to design, develop, and manufacture RNA-based biologic products.
-
Low Cost Vaccine, Patch Device Produce Immune Responses
Tests with lab mice show one dose of a lower cost Covid-19 vaccine given with a needle-free patch generates strong antibody and cellular immune responses.